Prevalance of Celiac Disease in Patients with Inflammatory Bowel Disease in Turkish Population

Table 1

Demographic data, IBD treatments, and anemia profiles of the patients in the study.

	CrD	UC
Gender (female/male) ()	151/212	183/213	0.263
Mean age (years) (SD)			0.157
Mean duration of disease (years) (SD)	6.42 (±5.7)	8.29 (±6.8)	<0.001
Mean hemoglobin (g/dL) (SD) (13.5–17.5)			0.026
Mean ferritin (ng/mL) (SD) (23.9–336.2)			0.001
Mean transferrin saturation (%) (SD) (15–50)		11.9 (10.1)	0.318
Received treatment for anemia (, %)	151 (41.59%)	148 (37.37%)	0.255
Did not use NSAID () (%)	48 (13.22%)	8 (2.02%)	<0.001
Used NSAID () (%)	315 (86.77%)	388 (97.97%)
Used steroids () (%)	258 (71.07%)	193 (48.73%)	<0.001
Used immunomodulatory agents () (%)	256 (70.52%)	122 (30.80%)	<0.001
Used biologic agents () (%)	107 (29.47%)	28 (7.07%)	<0.001

Chi-squared test; Mann–Whitney test. CrD: Chron’s disease; UC: ulcerative colitis; SD: standard deviation; NSAID: nonsteroidal anti-inflammatory drug; g/dL: gram per decilitre; ng/mL: nanogram per millilitre.